Skip to content

Kidney Failure Classifications: Acute and Chronic

Kidney issues can be classified as acute or chronic, both of which require attention.

Kidney Malfunctions: Acute and Persistent
Kidney Malfunctions: Acute and Persistent

Kidney Failure Classifications: Acute and Chronic

Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD): Understanding the Differences

Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) are two distinct conditions that affect the kidneys, each requiring different approaches for management.

Acute Kidney Injury (AKI) is commonly caused by sudden reductions in kidney blood flow due to trauma, severe illness (e.g., sepsis), surgery, or nephrotoxic drugs such as certain antibiotics and NSAIDs. The most frequent pathological cause is acute tubular necrosis, often due to ischemia or toxins. Treatment focuses on managing fluid balance, stopping harmful medications, treating underlying causes like infection or heart failure, and, if needed, dialysis to support kidney function temporarily. AKI requires urgent supportive care and addressing reversible causes.

On the other hand, CKD primarily results from long-standing conditions like diabetes mellitus, hypertension, and glomerulonephritis. It usually progresses silently until later stages. Management aims to slow disease progression and address complications by controlling the underlying cause (e.g., tight glucose and blood pressure control), using pharmacotherapy such as RAAS inhibitors and SGLT2 inhibitors, monitoring cardiovascular risk, and adjusting diet and medications appropriately. Preventing AKI in CKD patients is critical to avoid worsening kidney function.

Both conditions can be categorized into stages based on the level of kidney function and the presence of complications. For instance, in Stage 3 of CKD, kidney function is moderately reduced, and individuals may experience noticeable symptoms and complications. In Stage 5, also known as end stage renal disease (ESRD), kidney function is severely compromised, and individuals often require kidney replacement therapy, such as dialysis or a transplant, to sustain life.

Diagnosing both conditions involves a medical history review, physical examination, laboratory tests, imaging studies, and urinalysis. Key diagnostic markers for AKI include estimated glomerular filtration rate (eGFR), serum creatinine levels, and urine tests, while for CKD, these include eGFR, serum creatinine levels, blood pressure, and urine albumin levels.

Common symptoms of CKD include fatigue and weakness, nausea and vomiting, persistent itching, foamy or bubbly urine, increased or decreased urination, blood in the urine, swelling in the legs, ankles, or face, a loss of appetite, muscle cramps, high blood pressure, difficulty sleeping, cognitive changes, and trouble concentrating.

In the case of AKI, symptoms may include rapid onset, decreased urine output, fluid overload, electrolyte imbalance, and shortness of breath, among others. AKI can occur within a few hours or days, while CKD progresses more slowly over time.

In conclusion, understanding the differences between AKI and CKD is essential for effective management and treatment. Preventing AKI in CKD patients is crucial to avoid worsening kidney function, and early diagnosis and intervention can significantly improve outcomes.

  1. Science has yet to develop a cure for Chronic Kidney Disease (CKD), a condition primarily caused by long-standing conditions like diabetes mellitus, hypertension, and glomerulonephritis.
  2. In contrast, Acute Kidney Injury (AKI), commonly caused by sudden reductions in kidney blood flow, can sometimes be reversible with prompt medical-conditions management, such as stopping harmful medications and addressing reversible causes.
  3. Preventing AKI in CKD patients becomes essential for maintaining health-and-wellness since AKI can exacerbate CKD and worsen kidney function.
  4. The health of a person with chronic-diseases like CKD can be managed by controlling the underlying causes, using pharmacotherapy such as RAAS inhibitors and SGLT2 inhibitors, monitoring cardiovascular risk, adjusting diet, and medications appropriately, rather than focusing on a single treatment.
  5. In the case of chronic-kidney-disease, diagnosis involves evaluating a comprehensive medical history, conducting physical examinations, laboratory tests, imaging studies, and urinalysis to determine key diagnostic markers like eGFR, serum creatinine levels, blood pressure, and urine albumin levels.
  6. To ensure improved health-and-wellness outcomes, a person experiencing symptoms of chronic-diseases such as CKD should receive early diagnosis and intervention, as well as regular monitoring to catch complications related to chronic-diseases and chronic-kidney-disease in their early stages.

Read also:

    Latest